Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. KEGG DRUG DrugBank 薬物名（臨床試験情報から抽出） KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Nitrous oxide 💬 1件: Nitrous oxide2件: MEOPA; Nitrous Oxide; --2件: 34, 149 💬
2 Baclofen 💬 1件: Baclofen2件: Baclofen; Kemstro; 2件: GABBR1,
GABBR2 💬		7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
3 Botulinum toxin type A 💬 1件: Botulinum toxin type A8件: Botox; Botulinum toxin A; BOTULINUM TOXIN TYPE A; BTX-A; Dysport; IncobotulinumtoxinA; OnabotulinumtoxinA; Xeomin; 1件: SNAP25 💬2件: Insulin secretion, Synaptic vesicle cycle 💬14件: 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 💬
4 Sodium oxybate 💬 1件: Sodium oxybate1件: Sodium Oxybate; --2件: 6, 149 💬
5 Lacosamide 💬 1件: Lacosamide1件: Lacosamide; 2件: SCN3A,
SCN9A 💬		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
6 Fenfluramine 💬 1件: Fenfluramine2件: Fenfluramina; FENFLURAMINE; 5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬		10件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬4件: 140, 144, 145, 149 💬
7 Flunarizine 💬 1件: Flunarizine0件: 3件: CACNA1G,
CACNA1H,
CACNA1I 💬		8件: Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GnRH secretion, MAPK signaling pathway, Type II diabetes mellitus 💬-
8 Brivaracetam 💬 1件: Brivaracetam1件: Brivaracetam; 1件: SV2A 💬1件: ECM-receptor interaction 💬2件: 149, 309 💬
9 Triheptanoin 💬 1件: Triheptanoin1件: TRIHEPTANOIN; --10件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 💬
10 Padsevonil 💬 1件: Padsevonil1件: Padsevonil; 3件: SV2A,
SV2B,
SV2C 💬		1件: ECM-receptor interaction 💬1件: 149 💬